Juan Armando Rodriguez-Oballe
Overview
Explore the profile of Juan Armando Rodriguez-Oballe including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
7
Citations
112
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Laserna-Mendieta E, Navarro P, Casabona-Frances S, Savarino E, Amorena E, Perez-Martinez I, et al.
United European Gastroenterol J
. 2024 Jan;
12(5):585-595.
PMID: 38284792
Background: Swallowed topical corticosteroids (tC) are common therapy for patients with eosinophilic esophagitis (EoE). Widely heterogeneous results have occurred due to their active ingredients, formulations and doses. Objective: To assess...
2.
Laserna-Mendieta E, Navarro P, Casabona-Frances S, Savarino E, Perez-Martinez I, Guagnozzi D, et al.
Dig Liver Dis
. 2023 May;
55(8):1165-1166.
PMID: 37230859
No abstract available.
3.
Laserna-Mendieta E, Navarro P, Casabona-Frances S, Savarino E, Perez-Martinez I, Guagnozzi D, et al.
Dig Liver Dis
. 2022 Oct;
55(3):350-359.
PMID: 36280437
Background: Direct comparisons of childhood- and adulthood-onset eosinophilic esophagitis (EoE) are scarce. Aim: To compare disease characteristics, endoscopic and histological features, allergic concomitances and therapeutic choices across ages. Methods: Cross-sectional...
4.
Navarro P, Laserna-Mendieta E, Casabona S, Savarino E, Perez-Fernandez M, Ghisa M, et al.
United European Gastroenterol J
. 2022 May;
10(5):507-517.
PMID: 35578565
Background: Poor adherence to clinical practice guidelines for eosinophilic esophagitis (EoE) has been described and the diagnostic delay of the disease continues to be unacceptable in many settings. Objective: To...
5.
Demcsak A, Soos A, Kincses L, Capunge I, Minkov G, Kovacheva-Slavova M, et al.
Pancreatology
. 2020 Sep;
20(7):1323-1331.
PMID: 32948430
Background: Acid suppressing drugs (ASD) are generally used in acute pancreatitis (AP); however, large cohorts are not available to understand their efficiency and safety. Therefore, our aims were to evaluate...
6.
Laserna-Mendieta E, Casabona S, Savarino E, Perello A, Perez-Martinez I, Guagnozzi D, et al.
Clin Gastroenterol Hepatol
. 2020 Jan;
18(13):2903-2911.e4.
PMID: 31988045
Background & Aims: Topical steroids, proton pump inhibitors (PPIs), and dietary interventions are recommended first- and second-line therapies for eosinophilic esophagitis (EoE). We investigated differences in their effectiveness in a...
7.
Parniczky A, Lantos T, Toth E, Szakacs Z, Godi S, Hagendorn R, et al.
Pancreatology
. 2019 May;
19(4):488-499.
PMID: 31068256
Background: Unwarranted administration of antibiotics in acute pancreatitis presents a global challenge. The clinical reasoning behind the misuse is poorly understood. Our aim was to investigate current clinical practices and...